Description
Trexoglo HMT Cream is a dermatological combination therapy used for the treatment of melasma, hyperpigmentation, dark spots, and uneven skin tone. The unique triple-action formula of Hydroquinone, Tretinoin, and Mometasone Furoate provides synergistic effects to lighten skin, reduce inflammation, and promote skin renewal.
This combination is clinically proven to effectively reduce excess melanin production, correct pigment irregularities, and improve the overall texture and appearance of the skin. Trexoglo HMT is especially beneficial for individuals dealing with post-inflammatory hyperpigmentation, age spots, freckles, and chloasma.
Mechanism of Action
Each active ingredient in Trexoglo HMT plays a distinct and complementary role in treating pigmentation disorders:
Hydroquinone (0.1%) – A potent skin depigmenting agent that works by inhibiting the enzyme tyrosinase, which is responsible for melanin synthesis. This leads to the gradual lightening of dark patches, freckles, and melasma spots.
Tretinoin (0.025%) – A vitamin A derivative (retinoid) that promotes cell turnover, helps remove dead pigmented skin cells, and enhances the penetration of Hydroquinone. It also reduces fine lines and smooths the skin texture, promoting rejuvenation.
Mometasone Furoate (0.1%) – A topical corticosteroid that reduces inflammation, redness, and itching associated with melasma and other inflammatory skin conditions. It prevents irritation often caused by the exfoliating and bleaching agents.
Together, this combination provides a complete skin-lightening therapy — reducing pigmentation, controlling inflammation, and rejuvenating the skin for a brighter and even complexion.
Indications for Use
Trexoglo HMT Cream is indicated for:
- Melasma (chloasma) – dark patches on the face due to hormonal changes or sun exposure.
- Post-inflammatory hyperpigmentation (PIH) – dark marks left after acne or injury.
- Freckles, age spots, and lentigines.
- Uneven skin tone and discoloration.
- Other pigmentary disorders where skin lightening is desired.
- Regular use under medical supervision provides visible improvement in skin tone and texture within a few weeks.
Dosage and Administration
Apply a thin layer of Trexoglo HMT Cream once daily in the evening or as directed by a dermatologist.
Cleanse and pat dry the affected area before application.
Avoid contact with eyes, nostrils, mouth, and open wounds.
Use sunscreen during the day, as the skin becomes more sensitive to UV light during treatment.
Treatment duration should be as per the physician’s recommendation; prolonged use should be avoided.
Possible Side Effects
While generally safe under medical supervision, some users may experience mild, temporary reactions such as:
- Redness or irritation
- Mild burning or stinging
- Peeling or dryness
- Temporary lightening of surrounding skin
- If severe irritation or allergic reactions occur, discontinue use and consult a dermatologist immediately.
Precautions
Here are some of the precaution that we must follow while using the medicine
- For external use only.
- Avoid prolonged or unsupervised use to prevent skin thinning or steroid-related side effects.
- Not suitable for pregnant or breastfeeding women without a doctor’s advice.
- Avoid exposure to sunlight and tanning devices.
- Always apply broad-spectrum sunscreen during the day to prevent recurrence of pigmentation.
- Do not use with other skin-lightening agents or exfoliants unless prescribed.
Storage Instruction
- keep it away from direct sunlight
- keep it in cool and dry place
- keep away from children
